Latest
-
Precision Cancer Medicines for Colon Cancer
Genomic testing identifies genetic targets that can be treated with precision cancer medicines avoiding chemotherapy
-
FDA Grants Accelerated Approval to Sonrotoclax (Begalzi) for Relapsed or Refractory Mantle Cell Lymphoma
A new targeted therapy called Beqalzi offers hope for patients whose mantle cell lymphoma has returned or stopped responding to treatment, with more than half of patients in clinical testing experiencing tumor shrinkage.
Welcome to CancerConnect
CancerConnect is a unique resource that brings patients, caregivers, advocates and experts together – individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, and treatment and the support of other individuals being treated at some of the best cancer centers. CancerConnect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey. Search the over 7000 articles on the management of cancer.
